MITOMED AS
Operating
Drive preklinisk og klinisk forskning og utvikle ernærings- og
biomedisinske produkter, alene eller i samarbeid med andre.
Organization
- CEO
- GK
- Chairman of the board
- GK
- Years since formation
- 6 years
- since Feb 12, 2020
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 300,000
- 1 share class
- Total number of shareholders
- 5
- 3 companies, 2 persons
- Belongs to group of
Financials
- Annual total result 2025
- -1,273,746
- NOK
- Total equity 2025
- -1,279,191
- NOK
Last update: Jun 24, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
GK | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
GK | Chairman | - |
RK | Board Member | 29.55 % directly 10 % indirectly 19.55 % |
KA 1949 | Board Member | - |
KT | Board Member | - |
CB 1973 | Board Member | 1.16 % indirectly |
LN | Board Member | 3.86 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
RK | Board Member | 29.55 % directly 10 % indirectly 19.55 % |
TN 1941 | - | 8.37 % indirectly |
AJ 1958 | - | 7.76 % directly 5 % indirectly 2.76 % |
SD 1951 | - | 7.28 % indirectly |
SS 1948 | - | 5.37 % indirectly |
GL | - | 3.99 % indirectly |
BD 1985 | - | 3.93 % indirectly |
LN | Board Member | 3.86 % indirectly |
SN 1973 | - | 3.86 % indirectly |
MS 1974 | - | 2.68 % indirectly |
Last update: May 13, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 232,500 | 77.5 % | |
RK | Ordinary shares | 30,000 | 10 % |
| Ordinary shares | 15,000 | 5 % | |
AJ 1958 | Ordinary shares | 15,000 | 5 % |
M Under liquidation | Ordinary shares | 7,500 | 2.5 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 251,897Operating profit 2025: NOK -6,245,547Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 2,389,569 | 464,280 | 239,790 | 0 |
Annual Total Result | -1,273,746 | -236,410 | -296,046 | 85,680 | -11,592 |
Total assets | 842,102 | 2,514,234 | 829,637 | 804,043 | 400,469 |
Total liabilities | 2,121,293 | 2,560,542 | 639,535 | 317,894 | 0 |
Total equity | -1,279,191 | -46,308 | 190,103 | 486,149 | 400,469 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 2,389,569 | 464,280 | 239,790 | 0 |
Total operating costs | 1,258,856 | 2,624,721 | 760,326 | 154,110 | 11,592 |
Operating result | -1,258,856 | -235,151 | -296,046 | 85,680 | -11,592 |
Financial income/costs | -14,890 | -1,259 | 0 | 0 | 0 |
Profit before tax | -1,273,746 | -236,410 | -296,046 | 85,680 | -11,592 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | -1,273,746 | -236,410 | -296,046 | 85,680 | -11,592 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 500,000 | 0 | 0 | 0 | 0 |
Total current assets | 342,102 | 2,514,234 | 829,637 | 804,043 | 400,469 |
Total assets | 842,102 | 2,514,234 | 829,637 | 804,043 | 400,469 |
Short term debt | 1,809,338 | 2,560,542 | 639,535 | 317,894 | 0 |
Long term debt | 311,955 | 0 | 0 | 0 | 0 |
Total liabilities | 2,121,293 | 2,560,542 | 639,535 | 317,894 | 0 |
Contributed capital | 631,930 | 631,930 | 631,930 | 631,930 | 631,930 |
Retained earnings | -1,911,121 | -678,238 | -441,827 | -145,781 | -231,461 |
Total equity | -1,279,191 | -46,308 | 190,103 | 486,149 | 400,469 |
Total equity and liabilities | 842,102 | 2,514,234 | 829,637 | 804,043 | 400,469 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises